0 results for 'null'
JPMorgan Wins Dismissal in Chancery Case Over Zelle Compliance
Chancellor Kathaleen St.J. McCormick concluded that shareholder plaintiffs failed to adequately plead that JPMorgan's directors knew of and ignored concerns about the bank's compliance with reimbursement laws.Ninth Circuit Affirms Dismissal of Securities Claims Against Gaming Platform
The three-judge panel ruled that the shareholders hadn't provided adequate facts to support their claims that Skillz, represented by Latham & Watkins, misled them.Ninth Circuit Affirms Dismissal of Securities Claims Against Gaming Platform
The three-judge panel ruled that the shareholders hadn't provided adequate facts to support their claims that Skillz, represented by Latham & Watkins, misled them.7th Circuit Lets Shareholder Intervene in Mootness Fees Spat
"It seems to us that, as an investor in Akorn whose shares' value was affected by the merger and the mootness fees, Frank has a claim in common with the main action; how could it be otherwise?" Judge Frank Easterbrook wrote for the court.View more book results for the query "*"
Walmart Secures Dismissal of Drug Investigation Disclosure Claim
U.S. District Chief Judge Colm F. Connolly's decision is a win for the Latham & Watkins and Richards, Layton & Finger team that represented Walmart, CEO Doug McMillon and former CFO Brett Biggs.Manhattan Jury Finds Terraform, Do Kwon Liable in Crypto Civil Fraud Trial
U.S. District Judge Jed Rakoff of the Southern District of New York said he intends to rule on penalties no later than the first week of May, after receiving briefs from the defendants and the U.S. Securities and Exchange Commission.SEC Pauses Climate Disclosure Rule Amid Legal Challenges
"[T]he Commission will continue vigorously defending the Final Rules' validity in court and looks forward to expeditious resolution of the litigation," the SEC said.Massachusetts Court: 'Real Time' Clinical Trial Data Not Needed to Avoid Securities Claims
U.S. District Judge Angel Kelley wrote that Latham & Watkins-repped Homology Medicines Inc. "had no duty to disclose data in real time."'Failure Is Not Fraud': Dentons Partner, SEC Make Closing Arguments in Terraform Civil Fraud Trial
After hearing nearly two weeks of evidence in the civil fraud case, jurors in the Southern District of New York on Friday began deliberating on whether cryptocurrency company Terraform Labs and its founder Do Kwon defrauded investors by lying about the company's success.Download Now
Download Now
Download Now
Download Now